Genetic linkage analysis of growth factor loci and end-stage renal disease in African Americans

Kidney International

Volumn 51, Issue 3, 1997, Pages 819-825

  Freedman, Barry I ^a,b   Yu, Hongrun ^a   Spray, Beverly J ^a   Rich, Stephen S ^a   Rothschild, Cynthia B ^a   Bowden, Donald W ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b North Carolina Baptist Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH FACTOR;

ARTICLE; GENETIC LINKAGE; HUMAN; KIDNEY FAILURE; NEGRO; PRIORITY JOURNAL;

EID: 0030889401     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.115     Document Type: Article

References (42)

1. UNITED STATES RENAL DATA SYSTEM, USRDS: Annual Data Report, the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, August 1994.
2. FERGUSON R, GRIM CE, OPGENORTH TJ: A familial risk of ehronic renal failure among blacks on dialysis? J Clin Epidemiol 41:1189-1196, 1988
3. FREEDMAN BI, SPRAY BJ, TUTTLE AB, BUCKALEW VM JR: The familial risk of end-stage renal disease in African Americans. Am J Kidney Dis 21:387-393, 1993
4. BERGMAN S, KEY BA, KIRK KA, WARNOCK DG, ROSTAND SG: Kidney disease in the first-degree relatives of African Americans with hypertensive end stage renal disease. Am J Kidney Dis 27:341-346, 1996
5. WHITTLE JC, WHELTON PK, SEIDLER AJ, KLAG MJ: Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end stage renal disease? Arch Intern Med 151:1359-1364, 1991
6. BYRNE C, NEDELMAN J, LUKE RG: Race, socioeconomic status, and the development of end stage renal disease. Am J Kidney Dis 23:16-22, 1994
7. BKOWN DM, PROVOOST AP, DALY MJ, LANDER ES, JACOB HJ: Renal disease susceptibility and hypertension are under independent genetic control in the fawn-hooded rat. Nature Genet 12:44-31, 1996
8. NAHAS AM: Growth factors and glomerular sclerosis. Kidey Int 41(Suppl 36):S15-S20, 1992
9. ABBOUD HE: Growth factors in glomerulonephritis. Kidney Int 43: 252-267, 1993
10. NAKAJIMA M, HEWITSON TD, MATHEWS DC, KINCAID-SMlTH P: Platelet-derived growth factor mesangial deposits in mesangial IgA glomerulonephritis. Nephrol Dial Transplant 6:11-16, 1991
11. MEDCRAFT J, HIGMAN GA, SACHS JA, WHICHLOW CE, RAAFAT I, MOORE RH: Autoimmune renal disease and tumour necrosis factor β gene polymorphism. Clin Nephrol 411:63-68, 1993
12. FRAMPTON G, HILDRETH G, HARTLEY B, CAMERON JS: Could platelet derived growth factor have a role in the pathogenesis of lupus nephritis? Lancet 2:343, 1988
13. JACOB CO, FRONEK Z, LEWIS GD, KOO M, HANSEN JA, MCDELVITT HO: Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor α: Relevance to genetic predisposition to systemic lupus erythemalosus. Proc Natl Acad Sic USA 87:1233-1237, 1990
14. KOPP JB, MCCUNE BK, NOTKINS AL, SPORN MB, KLOTMAN PE: Increased expression of transforming growth factor beta TGFβ in HIV-transgenic mouse kidney. (abstract) J Am Soc Nephrol 3:600, 1992
15. DOI T, STRIKER LJ, QAULIFE C, CONTI FG, PALMITER R, BEHRINGER R, BKINSTEK R, STRIKER GE: Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulin-like growth factor-1. Am Pathol 131:398-403, 1988
16. DOI T, VLASSARA H, KIRSTEIN M, YAMADA Y, STKIKER GE, STKIKER LJ: Receptor specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc Natl Acad Sci USA 89:2873-2877, 1992
17. BLAKEMORE AIF, COX A, GONZALEZ AM, MASKILL JK, HUGHES ME, WILSON RM, WARD JD, DUFF GW: Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus. Hum Genet 97:369-374, 1996
18. KROLEWSKI AS, WARRAM JH, CHRISTLIEB AR, BUSICK EJ, KAHN CR: The changing natural history of nephropathy in type 1 diabetes. Am J Med 78:785-794, 1985
19. NIH/CEPH COLLABORATIVE MAPPING GROUP: A comprehensive genetic linkage map of the human genome. Science 258:67-86, 1992
20. PATTERSON H, MITCHELL PJ, COOPER CS, STRATTON MR: Dinucleotide repeat polymorphism at the SIS locus, (abstract) Nucl Acids Res 18:5917, 1990
21. MURRAY JC, BUETOW KH, WEBER JL, LUDWIGSEN S, SCHERPBIER-HEDDEMA T, QUILLEN J, SHIFFIELD VC, SUNDEN S, DUYK GM: A comprehensive human linkage map with centimorgan density. Science 265:2049-2054, 1994
22. KEMBERLING WJ, WESTON MD, MOOLER C, VAN AAREM A, CREMERS CWRJ, SUMEGI J, INC, PS, CONNOLLY C, MARTINI A, MILAMI M, TAMAYO ML, BERNAL J, GREENBERG J, AYUSO C: Gene mapping of Usher syndrome type IIa: Localization of the gene to a 2.1-cM segment on chromosome Iq41. Am J Hum Genet 56:216-223, 1995
23. UDALOVA IA, NEDOSPASOV SA, WEBB GC, CHAPLIN DD, TURETSKAYA RL: Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics 16:180-186, 1993
24. NEDOSPASOV SA, UDALOVA IA, KUPPASH DV, TURETSKAYA RL: DNA sequence polymorphisms at the human tumor necrosis factor (TNF) locus; Numerous TNF/lymphotoxin alleles tagged by two closely linked microsatellites in the upstream region of the lymphotoxin (TNF-beta) gene. J Immunol 147:1053-1059, 1991
25. TARLOW JK, BLAKEMORE AIF, LENNARD A, SOLARI R, HUGHES HN, STEINKASSERER, A, DUFF GW: Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 91:403-404, 1993
26. WEBER JL, MAY PE: Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet 44:388-396, 1989
27. SAGE: Statistical Analysis for Genetic Epidemiology, Release 2.2. Computer program package available from the Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, 1994
28. RISCH N: Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am J Hum Genet 46:229-241, 1990
29. RISCH N: Linkage strategies for genetically complex traits. III. The effect of marker polymorphism on affected relative pairs. Am J Hum Genet 46:242-253, 1990
30. FREEDMAN BI, TUTTLE AB, SPRAY BJ: Familial predisposition to nephropathy in African Americans with non-insulin-dependent diabetes mellitus. Am J Kidney Dis 25:710-713, 1995
31. KRUGLYAK L, LANDER ES: Complete multipoint sib pair analysis of qualitative and quantitative traits. Am J Hum Genet 57:439-454, 1995
32. GYAPAY G, MORISSETTE J, VIGNAL A, DIB C, FIZAMES C, MILLASSEAU P, MARC S, BERNARDI G, LATHROP M, WEISSENBACH J: The 1993-94 Genethon human genetic linkage map. Nature Genet 7:246-339, 1994
33. PAYAMI H, JOE S, FARID NR, STENZKY V, CHAN SH, YEO PP, CHEAH JS, THOMSON G: Relative predispositional effects of marker alleles with disease: HLA-DR4 alleles and Graves disease. Am J Hum Genet 45:541-6, 1989
34. FOGO A: Internephron heterogeneity of growth factors and sclerosis. Kidney Int 45(Suppl 45):S24-S26, 1994
35. STRIKER GE, PETEN EP, YANG CW, STRIKER LJ: Glomerulosclerosis: studies of its pathogenesis in humans and animals, in Extracellular Matrix in the Kidney, edited by KOIDE H, HAYASHI T, Contrib Nephrol 107:124-131, 1994
36. NEILSON EG: Pathogenesis and therapy of interstitial nephritis. Kidney Int 35:1257-1270, 1989
37. QUALHEIM RE, ROSTAND SG, KIRK KA, RUTSKY DA, LUKE RG: Changing patterns of end-stage renal disease due to hypertension. Am J Kidney Dis 18:336-343, 1991
38. SCHLESSINGER SD, TANKERSLEY MR, CURTIS JJ: Clinical documentation of end stage renal disease due to hypertension. Am J Kidney Dis 23:655-660, 1994
39. PERNEGER TV, WHELTON PK, KLAG MJ, ROSSITER KA: Diagnosis of hypertensive end stage renal disease: Effect of patient's race. Am J Epidemiol 141:10-15, 1995
40. JEUNEMAITRE X, SOUBRIER F, KOTELEVTSEV Y, LIFTON RP, WILLIAMS CS, CHARRU A, HUNT SC, HOPKINS PN, WILLIAMS RR, LALOUEL JM, CORVOL P: Molecular basis of human hypertension: Role of angiotensinogen. Cell 71:169-180, 1992
41. PETTIT DJ, SAAD MF, BENNET PH, NELSON RG, KNOWLER WC: Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 33:438-443, 1990
42. SEAOUIST ER, GOETZ FC, RICH S, BARBOSA J: Familial clustering of diabetic kidney disease: Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320:1161-1165, 1989